Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: Implications for using nonhuman primate AIDS models to test vaccines and therapeutics

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 11234-11238

  Parker, R A ^a   Regan, M M ^a   Reimann, K A ^a  

^a Deaconess Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CALCULATION; CLINICAL RESEARCH; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MODEL; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MACACA MULATTA; RNA, VIRAL; SAMPLE SIZE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRAL LOAD;

EID: 0034756397     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.11234-11238.2001     Document Type: Article

References (23)

1. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
2. Locally weighted regression: An approach to regression analysis by local fitting
3. Satterthwaite's formula
4. Levene's robust test of homogeneity of variances
5. Progress and challenges in therapies for AIDS in nonhuman primate models
6. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
7. Emergence of CTL coincides with the clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys
8. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient post-inoculation antiretroviral treatment
9. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
10. The chimpanzee and other non-human-primate models in HIV-1 vaccine research
11. The role of nonhuman primates in the development of an AIDS vaccine
12. National Research Council
13. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay
14. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses
15. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
16. HIV chemotherapy
17. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
18. Effect of complement consumption by cobra venom factor (CVF) on the course of primary infection with simian immunodeficiency virus in rhesus monkeys
19. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: Predictive value for disease progression
20. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection
21. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction
22. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival